门诊蓝激光联合类固醇注射治疗出血性与非出血性声带息肉
回顾性分析29例声带息肉患者接受门诊蓝激光联合病灶内类固醇注射治疗,比较出血性与非出血性息肉的疗效。出血性息肉完全消退率显著高于非出血性(95.2% vs. 62.5%,p=0.022),VHI-10改善两组无显著差异(p=0.208),除jitter外声学参数无显著差异。
要点
- 出血性声带息肉门诊蓝激光联合类固醇注射后完全消退率95.2%,显著高于非出血性62.5%。
- 两组VHI-10评分改善无显著差异(10.2 vs. 6.33分,p=0.208)。
- 除jitter(p=0.017)外,两组声学参数无显著差异。
核心结论
- 出血性声带息肉对门诊蓝激光联合病灶内类固醇注射的应答优于非出血性息肉。
研究设计与样本
- 回顾性病历与视频记录审查,纳入2023年6月至2025年8月一家三级转诊中心接受门诊蓝激光联合病灶内类固醇注射的声带息肉患者29例。
- 平均随访12.79±12.31周。
主要发现
- 出血性息肉组VHI-10平均下降10.2±6.76分,非出血性组下降6.33±7.14分(p=0.208)。
- 出血性组完全消退率95.2%,非出血性组62.5%(p=0.022)。
- 除jitter(p=0.017)外,两组声学参数无显著差异。
- 两组人口学变量无显著差异。
关键数值与推荐
- 完全疾病消退率:出血性组95.2% vs. 非出血性组62.5%(p=0.022)。
- VHI-10评分变化:出血性组-10.2±6.76分 vs. 非出血性组-6.33±7.14分(p=0.208)。
- jitter参数两组差异有统计学意义(p=0.017)。
临床怎么用
- 门诊蓝激光联合类固醇注射可作为声带息肉的治疗选择,出血性息肉可能获益更明显。
- 非出血性息肉完全消退率较低,需结合患者情况个体化评估。
局限性
- 回顾性研究,样本量较小(29例),非出血性亚组仅8例。
- 随访时间较短(平均12.79周),缺乏长期疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the correlation between the morphology of vocal fold polyps, hemorrhagic versus nonhemorrhagic, and treatment outcome following office-based blue laser therapy with intralesional steroid injection. METHODS: All the medical records and video recordings of patients diagnosed with vocal fold polyps who underwent office-based blue laser therapy with intralesional steroid injection at a tertiary referral center between June 2023 and August 2025 were reviewed. Vocal fold polyps were classified as hemorrhagic versus nonhemorrhagic. The treatment outcome measures included the Voice Handicap Index-10 (VHI-10) score, acoustic parameters, maximum phonation time (MPT), and disease regression. The mean follow-up period was 12.79 ± 12.31 weeks. RESULTS: A total of 29 patients with vocal fold polyps were included in the study. Twenty-one patients had hemorrhagic polyps, while the remaining had nonhemorrhagic polyps. No significant differences in the demographic variables were noted between the two subgroups. The mean VHI-10 score in the hemorrhagic polyp subgroup decreased by 10.2 ± 6.76 points, compared to 6.33 ± 7.14 points in the nonhemorrhagic subgroup (p = 0.208). There was a significant difference in complete disease regression between the hemorrhagic and nonhemorrhagic subgroups (95.2% vs. 62.5% p = 0.022). No significant differences were observed in any of the acoustic parameters between the two subgroups except for jitter (p = 0.017). CONCLUSION: The results of this investigation indicate that hemorrhagic vocal fold polyps respond better to office-based blue laser therapy with intralesional steroid injection than nonhemorrhagic polyps.
引用
- Hamdan AL, Abou Raji Feghali P, Ghzayel L, et al. Office-Based Blue Laser Therapy and Steroid Injection of Hemorrhagic and Nonhemorrhagic Vocal Fold Polyp. Laryngoscope. 2026. PMID: 42265571. doi:10.1002/lary.70671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。